Literature DB >> 23773394

Dosimetric impact of the interplay effect during stereotactic lung radiation therapy delivery using flattening filter-free beams and volumetric modulated arc therapy.

Chin Loon Ong1, Max Dahele, Ben J Slotman, Wilko F A R Verbakel.   

Abstract

PURPOSE: We investigated the dosimetric impact of the interplay effect during RapidArc stereotactic body radiation therapy for lung tumors using flattening filter-free (FFF) beams with different dose rates. METHODS AND MATERIALS: Seven tumors with motion ≤20 mm, treated with 10-MV FFF RapidArc, were analyzed. A programmable phantom with sinusoidal longitudinal motion (30-mm diameter "tumor" insert; period = 5 s; individualized amplitude from planning 4-dimensional computed tomography) was used for dynamic dose measurements. Measurements were made with GafChromic EBT III films. Plans delivered the prescribed dose to 95% of the planning target volume, created by a 5-mm expansion of the internal target volume. They comprised 2 arcs and maximum dose rates of 400 and 2400 MU/min. For 2400 MU/min plans, measurements were repeated at 3 different initial breathing phases to model interplay over 2 to 3 fractions. For 3 cases, 2 extra plans were created using 1 full rotational arc (with contralateral lung avoidance sector) and 1 partial arc of 224° to 244°. Dynamic and convolved static measurements were compared by use of gamma analysis of 3% dose difference and 1 mm distance-to-agreement.
RESULTS: For 2-arc 2400 MU/min plans, maximum dose deviation of 9.4% was found in a single arc; 7.4% for 2 arcs (single fraction) and <5% and 3% when measurements made at 2 and 3 different initial breathing phases were combined, simulating 2 or 3 fractions. For all 7 cases, >99% of the area within the region of interest passed the gamma criteria when all 3 measurements with different initial phases were combined. Single-fraction single-arc plans showed higher dose deviations, which diminished when dose distributions were summed over 2 fractions. All 400 MU/min plans showed good agreement in a single fraction measurement.
CONCLUSION: Under phantom conditions, single-arc and single-fraction 2400 MU/min FFF RapidArc lung stereotactic body radiation therapy is susceptible to interplay. Two arcs and ≥2 fractions reduced the effect to a level that appeared unlikely to be clinically significant.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23773394     DOI: 10.1016/j.ijrobp.2013.03.038

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  38 in total

1.  Interplay effect modeling in stereotactic body radiotherapy treatment of liver cancer using volumetric modulated arc therapy.

Authors:  Deepak Thaper; Arun S Oinam; Rose Kamal; Gaganpreet Singh; Bhumika Handa; Vivek Kumar; Hanuman P Yadav
Journal:  Phys Eng Sci Med       Date:  2021-02-04

2.  Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy.

Authors:  Marguerite Tyran; Agnes Tallet; Michel Resbeut; Marjorie Ferre; Veronique Favrel; Pierre Fau; Laurence Moureau-Zabotto; Julien Darreon; Laurence Gonzague; Ahcene Benkemouche; Leonel Varela-Cagetti; Naji Salem; Bertrand Farnault; Marie-Aimee Acquaviva; Hugues Mailleux
Journal:  J Appl Clin Med Phys       Date:  2018-06-30       Impact factor: 2.102

3.  Under-reported dosimetry errors due to interplay effects during VMAT dose delivery in extreme hypofractionated stereotactic radiotherapy.

Authors:  Tobias Gauer; Thilo Sothmann; Oliver Blanck; Cordula Petersen; René Werner
Journal:  Strahlenther Onkol       Date:  2018-02-15       Impact factor: 3.621

4.  Investigation of 4D dose in volumetric modulated arc therapy-based stereotactic body radiation therapy: does fractional dose or number of arcs matter?

Authors:  Takashi Shintani; Mitsuhiro Nakamura; Yukinori Matsuo; Yuki Miyabe; Nobutaka Mukumoto; Takamasa Mitsuyoshi; Yusuke Iizuka; Takashi Mizowaki
Journal:  J Radiat Res       Date:  2020-03-23       Impact factor: 2.724

5.  Asymmetric margin setting at the cranial and caudal sides in respiratory gated and non-gated stereotactic body radiotherapy for lung cancer.

Authors:  Yoshihiro Ueda; Shingo Oohira; Masaru Isono; Masayoshi Miyazaki; Teruki Teshima
Journal:  Br J Radiol       Date:  2015-12-23       Impact factor: 3.039

6.  Evaluation of the target dose coverage of stereotactic body radiotherapy for lung cancer using helical tomotherapy: A dynamic phantom study.

Authors:  Masahide Saito; Hidekazu Suzuki; Naoki Sano; Kazunari Ashizawa; Kazuya Yoshizawa; Yuki Shibata; Koji Ueda; Takafumi Komiyama; Kan Marino; Shinichi Aoki; Ryo Saito; Yoshiyasu Maehata; Hiroshi Onishi
Journal:  Rep Pract Oncol Radiother       Date:  2020-01-14

7.  SBRT treatment of multiple extracranial oligometastases using a single isocenter with distinct optimizations.

Authors:  Michael Trager; Joseph Salama; Fang-Fang Yin; Justus Adamson
Journal:  J Radiosurg SBRT       Date:  2017

8.  Software simulation of tumour motion dose effects during flattened and unflattened ITV-based VMAT lung SBRT.

Authors:  Marta Adamczyk; Marta Kruszyna-Mochalska; Anna Rucińska; Tomasz Piotrowski
Journal:  Rep Pract Oncol Radiother       Date:  2020-06-11

9.  Dosimetric comparison of dynamic conformal arc integrated with segment shape optimization and variable dose rate versus volumetric modulated arc therapy for liver SBRT.

Authors:  Deepak Thaper; Rose Kamal; Gaganpreet Singh; Arun S Oinam; Hanuman P Yadav; Rishabh Kumar; Vivek Kumar
Journal:  Rep Pract Oncol Radiother       Date:  2020-05-20

10.  Automation and integration of a novel restricted single-isocenter stereotactic body radiotherapy (a-RESIST) method for synchronous two lung lesions.

Authors:  Lana Sanford Critchfield; Justin Visak; Mark E Bernard; Marcus E Randall; Ronald C McGarry; Damodar Pokhrel
Journal:  J Appl Clin Med Phys       Date:  2021-05-25       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.